Skip to main content
. 2024 Jul 8;14(13):2014. doi: 10.3390/ani14132014

Table 3.

Peroxidase content of the Chilean meagre mucus samples from acute and chronic hypoxia experiments.

Experiment Time Point Treatment Peroxidase Activity (U mg−1) Amount of Peroxidase per 100 µg of Total Protein Extracts (µg)
Acute hypoxia After hypoxia (3 h) Normoxia 0.73 ± 0.42 0.07 ± 0.03
Hypoxia 0.97 ± 0.26 0.09 ± 0.02
After
immunostimulation
N-PBS 0.20 ± 0.06 a 0.04 ± 0.00
N-VA 0.46 ± 0.01 bc 0.05 ± 0.00
H-PBS 0.33 ± 0.01 ac 0.05 ± 0.00
H-VA 0.60 ± 0.01 b 0.06 ± 0.00
24 h post-
immunostimulation
N-PBS 0.30 ± 0.05 ab 0.04 ± 0.00
N-LPS 0.85 ± 0.03 c 0.08 ± 0.00
N-VA 0.29 ± 0.06 ab 0.04 ± 0.00
H-PBS 0.34 ± 0.02 a 0.05 ± 0.00
H-LPS 0.14 ± 0.01 bd 0.03 ± 0.00
H-VA 0.10 ± 0.01 d 0.03 ± 0.00
Chronic hypoxia After intermittent
hypoxia (6 weeks)
Normoxia 3.26 ± 0.00 0.52 ± 0.00
Hypoxia 3.32 ± 0.03 0.53 ± 0.00
6 days post-
immunostimulation
N-PBS 0.05 ± 0.01 a 0.03 ± 0.00
N-LPS 2.57 ± 0.01 b 0.42 ± 0.00
H-PBS 0.65 ± 0.04 c 0.12 ± 0.01
H-LPS 0.74 ± 0.06 c 0.13 ± 0.01

Results expressed as mean ± SD. The letters indicate statistically significant differences between groups (p ≤ 0.05). N: normoxia; H: hypoxia; PBS: non-stimulated group; LPS: group inoculated with LPS; VA: group inoculated with the inactivated vaccine.